Global Blood Therapeutics, Inc. (GBT) Social Stream



Global Blood Therapeutics, Inc. (GBT): $68.49

0.01 (+0.01%)

POWR Rating

Component Grades

Momentum

D

Stability

F

Sentiment

Quality

C

Add GBT to Watchlist
Sign Up

Industry: Biotech

Industry

NR

Ranked

#111 of 385

in industry

GLOBAL BLOOD THERAPEUTICS INC (GBT) Price Targets From Analysts

The tables below show the price targets and recommendations analysts covering GBT.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-12-06 17 $138 $30 $70.588 $68.11 3.64%
2021-12-13 17 $138 $30 $70.588 $68.11 3.64%
2021-12-20 17 $138 $30 $70.235 $68.11 3.12%
2022-01-03 17 $138 $30 $70.058 $68.11 2.86%
2022-01-06 17 $138 $30 $69.705 $68.11 2.34%
2022-01-28 17 $138 $30 $68.823 $68.11 1.05%
2022-02-01 17 $138 $28 $68.705 $68.11 0.87%
2022-02-16 17 $138 $28 $67.941 $68.11 -0.25%
2022-02-25 17 $138 $28 $65.352 $68.11 -4.05%
2022-02-28 17 $138 $31 $65.529 $68.11 -3.79%
2022-03-24 17 $138 $31 $65.5 $68.11 -3.83%
2022-03-28 17 $102 $31 $60.4 $68.11 -11.32%
2022-04-28 17 $102 $31 $61.312 $68.11 -9.98%
2022-05-06 17 $102 $31 $61.866 $68.11 -9.17%
2022-05-16 17 $102 $31 $61.2 $68.11 -10.15%
2022-06-10 17 $102 $31 $59.933 $68.11 -12.01%
2022-06-13 17 $102 $31 $60 $68.11 -11.91%
2022-08-05 17 $102 $31 $59.8 $68.11 -12.2%
2022-08-08 17 $102 $40 $66.5 $68.11 -2.36%
2022-08-09 17 $102 $49 $69.576 $68.11 2.15%

The Trend in the Analyst Price Target


GBT's average price target has moved down $0.17 over the prior 31 weeks.

GBT reports an average of 97.71% for its upside potential over the past 39 weeks.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2021-12-22 17 138 30 70.058 31.07 125.48%
2022-01-03 17 138 30 70.058 30.46 130%
2022-02-28 17 138 31 65.529 30.20 116.98%
2022-03-24 17 102 31 60.666 34.85 74.08%
2022-08-08 17 102 40 66.500 66.60 -0.15%

GBT Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
2.53 4 0 13 0 0 17

The Trend in the Broker Recommendations


GBT's average broker recommendation rating worsened by 0.25 over the prior 48 weeks.

The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.

  • In terms of how GLOBAL BLOOD THERAPEUTICS INC fares relative to stocks in the mid market cap category, note that its number of analysts covering the stock is higher than 2369.94% of that group.
  • In terms of how GLOBAL BLOOD THERAPEUTICS INC fares relative to Pharmaceutical Products stocks, note that its upside potential (average analyst target price relative to current price) is higher than 93.36% of that group.
  • GLOBAL BLOOD THERAPEUTICS INC's variance in analysts' estimates is lower than -2101.77% of stocks in the mid market cap category.
  • GLOBAL BLOOD THERAPEUTICS INC's average analyst price target is greater than 1880.34% of Pharmaceutical Products stocks.

In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to GLOBAL BLOOD THERAPEUTICS INC are FOLD, FGEN, and EVO.

Make investment decisions regarding GBT using the data that counts. Try POWR Ratings for free.


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!